158 related articles for article (PubMed ID: 11447076)
21. Does glycoprotein IIIa gene (Pl(A)) polymorphism influence clopidogrel resistance? : a study in older patients.
Papp E; Havasi V; Bene J; Komlosi K; Talian G; Feher G; Horvath B; Szapary L; Toth K; Melegh B
Drugs Aging; 2007; 24(4):345-50. PubMed ID: 17432927
[TBL] [Abstract][Full Text] [Related]
22. Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome.
Yakushkin VV; Zyuryaev IT; Khaspekova SG; Sirotkina OV; Ruda MY; Mazurov AV
Platelets; 2011; 22(4):243-51. PubMed ID: 21329420
[TBL] [Abstract][Full Text] [Related]
23. Lack of association between platelet glycoprotein IIb/IIIa receptor PlA polymorphism and coronary artery disease or carotid intima-media thickness.
Garg UC; Arnett DK; Folsom AR; Province MA; Williams RR; Eckfeldt JH
Thromb Res; 1998 Jan; 89(2):85-9. PubMed ID: 9630312
[No Abstract] [Full Text] [Related]
24. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
Cooke GE; Liu-Stratton Y; Ferketich AK; Moeschberger ML; Frid DJ; Magorien RD; Bray PF; Binkley PF; Goldschmidt-Clermont PJ
J Am Coll Cardiol; 2006 Feb; 47(3):541-6. PubMed ID: 16458133
[TBL] [Abstract][Full Text] [Related]
25. Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice.
Di Castelnuovo A; de Gaetano G; Benedetta Donati M; Iacoviello L
Am J Pharmacogenomics; 2005; 5(2):93-9. PubMed ID: 15813672
[TBL] [Abstract][Full Text] [Related]
26. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
Naimushin YA; Mazurov AV
Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313
[TBL] [Abstract][Full Text] [Related]
27. [Mean platelet volume: interactions with platelet aggregation activity and glycoprotein IIb-IIIa and Ib expression levels].
Khaspekova SG; Ziuriaev IT; Iakushkin VV; Naĭmushin IaA; Sirotkina OV; Zaĭtseva NO; Ruda MIa; Mazurov AV
Biomed Khim; 2014; 60(1):94-108. PubMed ID: 24749250
[TBL] [Abstract][Full Text] [Related]
28. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
[TBL] [Abstract][Full Text] [Related]
29. Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke.
Carter AM; Catto AJ; Bamford JM; Grant PJ
Stroke; 1999 Dec; 30(12):2606-11. PubMed ID: 10582985
[TBL] [Abstract][Full Text] [Related]
30. The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets.
O'Halloran AM; Curtin R; O'Connor F; Dooley M; Fitzgerald A; O'Brien JK; Fitzgerald DJ; Shields DC
Br J Haematol; 2006 Feb; 132(4):494-502. PubMed ID: 16412022
[TBL] [Abstract][Full Text] [Related]
31. Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study.
Aleksic N; Juneja H; Folsom AR; Ahn C; Boerwinkle E; Chambless LE; Wu KK
Circulation; 2000 Oct; 102(16):1901-5. PubMed ID: 11034936
[TBL] [Abstract][Full Text] [Related]
32. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
[TBL] [Abstract][Full Text] [Related]
33. The GPIIIa Pl(A) polymorphism in the progression of abdominal aortic atherosclerosis.
Mikkelsson J; Perola M; Kauppila LI; Laippala P; Savolainen V; Pajarinen J; Penttilä A; Karhunen PJ
Atherosclerosis; 1999 Nov; 147(1):55-60. PubMed ID: 10525125
[TBL] [Abstract][Full Text] [Related]
34. [Variations in glycoprotein IIb-IIIa (alphaIIb/beta3-integrin) content in healthy donors. Influence on platelet aggregation activity and efficacy of aspirin action].
Khaspekova SG; Sirotkina OV; Shimanova IuV; Mazurov AV
Biomed Khim; 2008; 54(3):361-71. PubMed ID: 18712091
[TBL] [Abstract][Full Text] [Related]
35. Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.
Carter AM; Ossei-Gerning N; Wilson IJ; Grant PJ
Circulation; 1997 Sep; 96(5):1424-31. PubMed ID: 9315527
[TBL] [Abstract][Full Text] [Related]
36. Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): no association with platelet fibrinogen binding.
Meiklejohn DJ; Urbaniak SJ; Greaves M
Br J Haematol; 1999 Jun; 105(3):664-6. PubMed ID: 10354127
[TBL] [Abstract][Full Text] [Related]
37. Reduced inhibition by abciximab in platelets with the PlA2 polymorphism.
Wheeler GL; Braden GA; Bray PF; Marciniak SJ; Mascelli MA; Sane DC
Am Heart J; 2002 Jan; 143(1):76-82. PubMed ID: 11773915
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes.
O'Connor FF; Shields DC; Fitzgerald A; Cannon CP; Braunwald E; Fitzgerald DJ
Blood; 2001 Dec; 98(12):3256-60. PubMed ID: 11719362
[TBL] [Abstract][Full Text] [Related]
39. No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitors.
Weber AA; Jacobs C; Meila D; Weber S; Zotz RB; Scharf RE; Kelm M; Strauer BE; Schrör K
Pharmacogenetics; 2002 Oct; 12(7):581-3. PubMed ID: 12360110
[TBL] [Abstract][Full Text] [Related]
40. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
J Clin Invest; 1986 Apr; 77(4):1272-7. PubMed ID: 3007578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
